The following table or figure may be downloaded to PowerPoint for personal use in teaching and presentations. This feature is available to all subscribers to the journal.

You MUST read and follow the guidelines at Request to Reproduce AJR Content if you are distributing or using AJR content beyond academic use (limited distribution, non-revenue producing, or educational purposes).

(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 1D. —60-year-old woman with insulinoma that was well controlled with octreotide, but who developed debilitating life-threatening symptoms when not receiving continuous octreotide therapy. Her fasting insulin dropped from preablation level of 40.1 µU/mL with octreotide therapy to 7.9 µU/mL without octreotide injections. Contrast-enhanced CT scan obtained 12 months after ablation shows sharply demarcated low-density area of ablated tissue surrounded by residual tumor that has grown since B and C.